Simulations Plus Inc
NASDAQ:SLP
Simulations Plus Inc
Cash Equivalents
Simulations Plus Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Simulations Plus Inc
NASDAQ:SLP
|
Cash Equivalents
$37m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
30%
|
CAGR 10-Years
14%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash Equivalents
$703.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash Equivalents
$175.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash Equivalents
$96.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Cash Equivalents
$235m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Simulations Plus Inc's Cash Equivalents?
Cash Equivalents
37m
USD
Based on the financial report for Feb 29, 2024, Simulations Plus Inc's Cash Equivalents amounts to 37m USD.
What is Simulations Plus Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash Equivalents growth was -6%. The average annual Cash Equivalents growth rates for Simulations Plus Inc have been -4% over the past three years , 30% over the past five years , and 14% over the past ten years .